Stay updated on Pembrolizumab with Radium-223 in mCRPC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Radium-223 in mCRPC Clinical Trial page.

Latest updates to the Pembrolizumab with Radium-223 in mCRPC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe Related Topics header and its links for Prostate cancer and MedlinePlus Genetics were removed, altering the page's navigation to related resources.SummaryDifference0.2%

- Check19 days agoChange DetectedAdded the topic tags 'Prostate cancer' and 'related topics: MedlinePlus Genetics' to enhance contextual linking, and updated the site revision label from v3.6.0 to v3.6.3.SummaryDifference0.2%

- Check33 days agoChange DetectedRemoved the 'Prostate cancer' tag and the 'MedlinePlus Genetics' related topics from the page. This changes how the study is categorized and surfaced in topic-based navigation and related links.SummaryDifference0.2%

- Check41 days agoChange DetectedThe page received new user-help and navigation sections, including How to Read a Study Record, Common Questions, How to Join a Study, and related topic links. The Interventions label was standardized from 'Intervention / Treatment' to 'Intervention/Treatment' and a new site revision tag (Revision: v3.6.0) was added.SummaryDifference0.6%

- Check48 days agoChange DetectedThe page now shows a new revision label: Revision: v3.5.5. The previous revision label Revision: v3.5.4 has been removed, reflecting an updated version of the page metadata.SummaryDifference0.1%

- Check69 days agoChange DetectedAdded Revision: v3.5.4 to the page, indicating a version update. Removed the related topics entries for Prostate cancer and MedlinePlus Genetics, and the 'related topics' label from the page's related topics section.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab with Radium-223 in mCRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Radium-223 in mCRPC Clinical Trial page.